Show simple item record

dc.contributor.authorNiego, Allen Grace
dc.contributor.authorRaspé, Olivier
dc.contributor.authorThongklang, Naritsada
dc.contributor.authorCharoensup, Rawiwan
dc.contributor.authorLumyong, Saisamorn
dc.contributor.authorStadler, Marc
dc.contributor.authorHyde, Kevin D
dc.date.accessioned2021-02-10T10:56:24Z
dc.date.available2021-02-10T10:56:24Z
dc.date.issued2021-01-13
dc.identifier.citationJ Fungi (Basel). 2021 Jan 13;7(1):51. doi: 10.3390/jof7010051.en_US
dc.identifier.pmid33451109
dc.identifier.doi10.3390/jof7010051
dc.identifier.urihttp://hdl.handle.net/10033/622731
dc.description.abstractThe oudemansielloid/xeruloid taxa Hymenopellis, Mucidula, Oudemansiella, and Xerula are genera of Basidiomycota that constitute an important resource of bioactive compounds. Numerous studies have shown antimicrobial, anti-oxidative, anti-cancer, anti-inflammatory and other bioactivities of their extracts. The bioactive principles can be divided into two major groups: (a) hydrophilic polysaccharides with relatively high molecular weights and (b) low molecular medium polar secondary metabolites, such as the antifungal strobilurins. In this review, we summarize the state of the art on biodiversity, cultivation of the fungi and bioactivities of their secondary metabolites and discuss future applications. Although the strobilurins are well-documented, with commercial applications as agrochemical fungicides, there are also other known compounds from this group that have not yet been well-studied. Polysaccharides, dihydro-citrinone phenol A acid, scalusamides, and acetylenic lactones such as xerulin, also have potential applications in the nutraceutical, pharmaceutical and medicinal market and should be further explored. Further studies are recommended to isolate high quality bioactive compounds and fully understand their modes of action. Given that only few species of oudemansielloid/xeruloid mushrooms have been explored for their production of secondary metabolites, these taxa represent unexplored sources of potentially useful and novel bioactive metabolites.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBasidiomycotaen_US
dc.subjectbioactive compoundsen_US
dc.subjectcultivationen_US
dc.subjectdiversityen_US
dc.subjecttaxonomyen_US
dc.titleTaxonomy, Diversity and Cultivation of the Oudemansielloid/Xeruloid Taxa Hymenopellis, Mucidula, Oudemansiella, and Xerula and with Respect to Their Bioactivities: A Review.en_US
dc.typeReviewen_US
dc.identifier.eissn2309-608X
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalJournal of fungi (Basel, Switzerland)en_US
dc.source.volume7
dc.source.issue1
refterms.dateFOA2021-02-10T10:56:25Z
dc.source.journaltitleJournal of fungi (Basel, Switzerland)
dc.source.countrySwitzerland


Files in this item

Thumbnail
Name:
Niego et al.pdf
Size:
4.474Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International